Abacus Wealth Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-17,549
Closed -$254K – 341
2026
Q2
$254K Sell
17,549
-62,198
-78% -$839K 0.03% 267
2026
Q1
$1.1M Buy
79,747
+740
+0.9% +$10.3K 0.1% 94
2025
Q4
$1.11M Buy
+79,007
New +$1.11M 0.11% 90
2025
Q3
– Sell
-15,515
Closed -$233K – 115
2025
Q2
$233K Buy
+15,515
New +$222K 0.04% 94
2025
Q1
– Sell
-10,120
Closed -$160K – 100
2024
Q4
$160K Buy
+10,120
New +$152K 0.02% 88

Other funds holding RDY

Abacus Wealth Partners's RDY Position: Q3 2026 in Review

Abacus Wealth Partners sold out of Dr. Reddy's Laboratories (RDY) in Q3 2026, closing a stake of 17,549 shares — an estimated $254K sold.

Abacus Wealth Partners first reported a position in RDY in Q4 2024 and held it in 5 quarters. The position peaked at $1.11M in Q4 2025. 236 funds tracked by Wall St. Rank hold RDY as of Q3 2026.

  • Abacus Wealth Partners reported no remaining Dr. Reddy's Laboratories position as of Q3 2026 after selling out during the quarter.
  • Abacus Wealth Partners sold 17,549 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $254K.
  • Abacus Wealth Partners first reported a position in Dr. Reddy's Laboratories in Q4 2024 and held it in 5 quarters.
  • Abacus Wealth Partners's Dr. Reddy's Laboratories position peaked at $1.11M in Q4 2025.
  • 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.

Based on Abacus Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.